<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31796528</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e811</StartPage><EndPage>e819</EndPage><MedlinePgn>e811-e819</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000008676</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To examine the association between prediagnostic plasma polyunsaturated fatty acids levels (PUFA) and amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">We identified 275 individuals who developed ALS while enrolled in 5 US prospective cohorts, and randomly selected 2 controls, alive at the time of the case diagnosis, matched on cohort, birth year, sex, ethnicity, fasting status, and time of blood draw. We measured PUFA, expressed as percentages of total fatty acids, using gas liquid chromatography and used conditional logistic regression to estimate risk ratios (RR) and 95% confidence intervals (CI) for the association between PUFA and ALS.</AbstractText><AbstractText Label="RESULTS">There was no association between total, n-3, and n-6 PUFA, eicosapentaenoic acid, or docosapentaenoic acid levels and ALS. Higher plasma &#x3b1;-linolenic acid (ALA) in men was associated with lower risk of ALS in age- and matching factor-adjusted analyses (top vs bottom quartile: RR = 0.21 [95% CI 0.07, 0.58], <i>p</i> for trend = 0.004). In women, higher plasma arachidonic acid was associated with higher risk (top vs bottom quartile: RR = 1.65 [95% CI 0.99, 2.76], <i>p</i> for trend = 0.052). Multivariable adjustment, including correlated PUFA, did not change the findings for ALA and arachidonic acid. In men and women combined, higher plasma docosahexaenoic acid (DHA) was associated with higher risk of ALS (top vs bottom quartile: RR = 1.56 [95% CI 1.01, 2.41], <i>p</i> for trend = 0.054), but in multivariable models the association was only evident in men.</AbstractText><AbstractText Label="CONCLUSIONS">The majority of individual PUFAs were not associated with ALS. In men, ALA was inversely and DHA was positively related to risk of ALS, while in women arachidonic acid was positively related. These findings warrant confirmation in future studies.</AbstractText><CopyrightInformation>&#xa9; 2019 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>&#xc9;ilis J</ForeName><Initials>&#xc9;J</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. poeor@channing.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjornevik</LastName><ForeName>Kjetil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furtado</LastName><ForeName>Jeremy D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolonel</LastName><ForeName>Laurence N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Marchand</LastName><ForeName>Loic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Marjorie L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Victoria L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shadyab</LastName><ForeName>Aladdin H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snetselaar</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manson</LastName><ForeName>JoAnn E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascherio</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Nutrition (&#xc9;.J.O., K.B., J.D.F., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (&#xc9;.J.O.), College of Medicine, University College Cork, Ireland; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M., V.L.S.), American Cancer Society, Atlanta, GA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Department of Epidemiology (L.S.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (J.E.M., A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN268201600001C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201600003C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS045893</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201600002C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201600004C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201600018C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurology. 2020 Feb 25;94(8):339-340</RefSource><PMID Version="1">31796529</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062706" MajorTopicYN="N">Prodromal Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31796528</ArticleId><ArticleId IdType="pmc">PMC7136057</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000008676</ArticleId><ArticleId IdType="pii">WNL.0000000000008676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner MR, Bowser R, Bruijn L, et al. . Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(suppl 1):19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JJ, Green P, John Mann J, Rapoport SI, Sublette ME. Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res 2015;1597:220&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339314</ArticleId><ArticleId IdType="pubmed">25498862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Li P, Hu X, Zhang F, Chen J, Gao Y. Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front Biosci 2011;16:2653&#x2013;2670.</Citation><ArticleIdList><ArticleId IdType="pubmed">21622201</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumil EF, Vohnoutka RB, Liu Y, Lee S, Shea TB. Omega-3 hastens and omega-6 delays the progression of neuropathology in a murine model of familial ALS. Open Neurol J 2017;11:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5748836</ArticleId><ArticleId IdType="pubmed">29387280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip PK, Pizzasegola C, Gladman S, et al. . The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One 2013;8:e61626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631166</ArticleId><ArticleId IdType="pubmed">23620776</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KC, O'Reilly EJ, Falcone GJ, et al. . Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol 2014;71:1102&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Kihira T, Kondo T, et al. . Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler 2007;8:300&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">17852010</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, Kalmijn S, Groeneveld GJ, et al. . Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;784:367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly &#xc9;J, Wang H, Weisskopf MG, et al. . Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve 2011;44:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc5;berg M, Nyberg J, Robertson J, et al. . Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood. J Neurol 2018;265:460&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834569</ArticleId><ArticleId IdType="pubmed">29285652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Hammar N, Malmstr&#xf6;m H, et al. . Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol 2017;81:718&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, et al. . Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008;70:1004&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011;10:75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly EJ, Bjornevik K, Schwarzschild MA, et al. . Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:194&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423442</ArticleId><ArticleId IdType="pubmed">29277115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, O'Reilly EJ, Berry JD, et al. . Prediagnostic plasma branched chain amino acids and the risk of amyotrophic lateral sclerosis. Neurology 2018;92:e2081&#x2013;e2088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512885</ArticleId><ArticleId IdType="pubmed">30429276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Zhang Z, O'Reilly EJ, et al. . Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 2019;92:e2089&#x2013;e2100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512888</ArticleId><ArticleId IdType="pubmed">30926684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y, Bertoia ML, Lenart EB, et al. . Origin, methods, and evolution of the three nurses' health studies. Am J Public Health 2016;106:1573&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981810</ArticleId><ArticleId IdType="pubmed">27459450</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimm EB, Giovannucci EL, Willett WC, et al. . Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">1678444</ArticleId></ArticleIdList></Reference><Reference><Citation>Calle EE, Rodriguez C, Jacobs EJ, et al. . The American Cancer Society Cancer Prevention Study II Nutrition cohort: rationale, study design, and baseline characteristics. Cancer 2002;94:2490&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pubmed">12015775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolonel LN, Henderson BE, Hankin JH, et al. . A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4482109</ArticleId><ArticleId IdType="pubmed">10695593</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GL, Manson J, Wallace R, et al. . Implementation of the women's health initiative study design. Ann Epidemiol 2003;13:S5&#x2013;S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">14575938</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend MK, Bao Y, Poole EM, et al. . Impact of pre-analytic blood sample collection factors on metabolomics. Cancer Epidemiology Biomarkers Prev 2016;25:823&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873428</ArticleId><ArticleId IdType="pubmed">26941367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankinson SE, Willett WC, Manson JE, et al. . Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pubmed">7658481</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 2004;160:26&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15229114</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997-2011. Neurol Clin Pract 2013;3:313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylin A, Kim MK, Donovan-Palmer A, et al. . Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 2005;162:373&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">16014782</ArticleId></ArticleIdList></Reference><Reference><Citation>Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008;168:1073&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">18794220</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; 2008.</Citation></Reference><Reference><Citation>Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001;21:4668&#x2013;4677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762345</ArticleId><ArticleId IdType="pubmed">11425894</ArticleId></ArticleIdList></Reference><Reference><Citation>Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006;137:241&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">16289892</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg 2003;38:564&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">12947278</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, Hu XZ, Jacobowitz DM, et al. . Alpha-linolenic acid is a potent neuroprotective agent against soman-induced neuropathology. Neurotoxicology 2012;33:1219&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">22884490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Fan C, Xu F, Tian C, Zhang F, Qi K. Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice. J Nutr Biochem 2010;21:954&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">19954955</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdge GC, Jones AE, Wootton SA. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002;88:355&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">12323085</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002;88:411&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12323090</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs CE, Kew S, Finnegan YE, et al. . Increased dietary alpha-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study. Nutr J 2014;13:113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274685</ArticleId><ArticleId IdType="pubmed">25496415</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler SR, Mote PL, Flegal JM. Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice. Age 2014;36:9659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082564</ArticleId><ArticleId IdType="pubmed">24816553</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuduki T, Honma T, Nakagawa K, Ikeda I, Miyazawa T. Long-term intake of fish oil increases oxidative stress and decreases lifespan in senescence-accelerated mice. Nutrition 2011;27:334&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">20621447</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 2009;297:E28&#x2013;E37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711665</ArticleId><ArticleId IdType="pubmed">19066317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain G, Schmitt F, Henriques A, et al. . Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One 2013;8:e64525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681796</ArticleId><ArticleId IdType="pubmed">23785402</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004;101:11159&#x2013;11164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, et al. . Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 2009;256:1236&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS surveillance pilot project. Amyotroph Lateral Scler 2012;13:69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">21929354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou MA, Rotem RS, Seals RM, Gredal O, Hansen J, Weisskopf MG. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol 2015;72:905&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotsopoulos J, Tworoger SS, Campos H, et al. . Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the nurses' health studies. Cancer Epidemiol Biomarkers Prev 2010;19:938&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852492</ArticleId><ArticleId IdType="pubmed">20332276</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumpertz R, Guijarro A, Pratley RE, Mason CC, Piomelli D, Krakoff J. Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism. PLoS One 2012;7:e41503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3404019</ArticleId><ArticleId IdType="pubmed">22911803</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest J, Garg M, Bilgin A, Grant R. Relationship between central and peripheral fatty acids in humans. Lipids Health Dis 2013;12:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679897</ArticleId><ArticleId IdType="pubmed">23710642</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>